Tue, 05/10/2016
HLAA provided written comments in response to the Food and Drug Administration’s (FDA) notice reopening the comment period for consideration of the Draft Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products (PSAPs).